Press

30 Million Euro Loan from the European Investment Bank for TB

VPM receives Funding for VPM1002 tuberculosis vaccine development in Africa. Read more!

News

Hope for the elderly and healthcare professionals in the corona pandemic

First participants receive VPM1002 in a late-stage phase III clinical trial in Germany. Read more!

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Next Year

The 13th International VPM Days 2021

On 23 and 24 September 2021, the 13th International VPM Days will take place! Here you can find the report of 2019.

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

More about us

News & Press

Event

30 Million Euro Loan from the EIB for TB

VPM receives 30 Million Euro Funding from the European Investment Bank for VPM1002 tuberculosis vaccine development in Africa. Read more or Stream the ceremony!

News

Hope for the elderly: First participants receive VPM1002 in a late-stage phase III clinical trial in Germany

Vakzine Projekt Management GmbH (VPM) announces that the first participants have been enrolled last week in the phase III trial that will include elderly participants. More!

News

SARS-CoV-2 study kicks off in Germany: First participant enrolled

First participant has been enrolled on May 25th in a phase III study that will include health care professionals. More!

News

First volunteer enrolled

Vakzine Projekt Management GmbH: First volunteer enrolled in Phase II/III Study of SIIPL Tdap vaccine in Comparison with Boostrix® in Healthy Participants. More!

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.
powered by webEdition CMS